Cargando…

Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia

INTRODUCTION: preeclampsia can be associated with future renal disease. OBJECTIVES: To measure changes in renal function overtime in patients with preeclampsia. METHODS: urine and serum samples from eleven patients with preeclampsia and eight patients with a normal pregnancy were obtained during pre...

Descripción completa

Detalles Bibliográficos
Autores principales: de Franco, Ylbe Palacios, Velazquez, Karina, Segovia, Natalia, Sandoval, Gladys, Gauto, Estefania, Palacios, Ylbe V. Franco, Palacios, Carlos R Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534005/
https://www.ncbi.nlm.nih.gov/pubmed/29782634
http://dx.doi.org/10.1590/2175-8239-JBN-3941
_version_ 1783421325096779776
author de Franco, Ylbe Palacios
Velazquez, Karina
Segovia, Natalia
Sandoval, Gladys
Gauto, Estefania
Palacios, Ylbe V. Franco
Palacios, Carlos R Franco
author_facet de Franco, Ylbe Palacios
Velazquez, Karina
Segovia, Natalia
Sandoval, Gladys
Gauto, Estefania
Palacios, Ylbe V. Franco
Palacios, Carlos R Franco
author_sort de Franco, Ylbe Palacios
collection PubMed
description INTRODUCTION: preeclampsia can be associated with future renal disease. OBJECTIVES: To measure changes in renal function overtime in patients with preeclampsia. METHODS: urine and serum samples from eleven patients with preeclampsia and eight patients with a normal pregnancy were obtained during pregnancy, postpartum, and 3 years after delivery. Urine podocalyxin, protein, and serum creatinine were measured. RESULTS: after 3 years, there were no significant differences in urinary podocalyxin in patients with or without preeclampsia: 4.34 ng/mg [2.69, 8.99] vs. 7.66 ng/mg [2.35, 13], p = 0.77. The same applied to urinary protein excretion: 81.5 mg/g [60.6, 105.5] vs. 43.2 mg/g [20.9, 139.3] p = 0.23. Serum creatinine was 0.86 mg/dL [0.7, 0.9] vs. 0.8 mg/dL [0.68, 1] p = 0.74 in those with and without preeclampsia. In normal patients, urinary podocalyxin decreased from 54.4 ng/mg [34.2, 76.9] during pregnancy to 7.66 ng/mg [2.35, 13] three years after pregnancy, p = 0.01. Proteinuria decreased from 123.5 mg/g [65.9, 194.8] to 43.2 mg/g [20.9, 139.3], p = 0.12. In preeclampsia patients, urinary podocalyxin decreased from 97.5 ng/mg [64.9, 318.4] during pregnancy to 37.1 ng/mg within one week post-partum [21.3, 100.4] p = 0.05 and 4.34 ng/mg [2.69, 8.99] three years after, p = 0.003. Proteinuria was 757.2 mg/g [268.4, 5031.7] during pregnancy vs. 757.2 mg/g [288.2, 2917] postpartum, p = 0.09 vs. 81.5 mg/g [60.6, 105.5] three years later, p = 0.01. Two patients still had proteinuria after 3 years. CONCLUSIONS: in preeclampsia patients, postpartum urinary podocalyxin decreased before proteinuria. After three years, serum creatinine, urinary podocalyxin, and protein tended to normalize, although some patients still had proteinuria.
format Online
Article
Text
id pubmed-6534005
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sociedade Brasileira de Nefrologia
record_format MEDLINE/PubMed
spelling pubmed-65340052019-06-17 Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia de Franco, Ylbe Palacios Velazquez, Karina Segovia, Natalia Sandoval, Gladys Gauto, Estefania Palacios, Ylbe V. Franco Palacios, Carlos R Franco J Bras Nefrol Original Articles INTRODUCTION: preeclampsia can be associated with future renal disease. OBJECTIVES: To measure changes in renal function overtime in patients with preeclampsia. METHODS: urine and serum samples from eleven patients with preeclampsia and eight patients with a normal pregnancy were obtained during pregnancy, postpartum, and 3 years after delivery. Urine podocalyxin, protein, and serum creatinine were measured. RESULTS: after 3 years, there were no significant differences in urinary podocalyxin in patients with or without preeclampsia: 4.34 ng/mg [2.69, 8.99] vs. 7.66 ng/mg [2.35, 13], p = 0.77. The same applied to urinary protein excretion: 81.5 mg/g [60.6, 105.5] vs. 43.2 mg/g [20.9, 139.3] p = 0.23. Serum creatinine was 0.86 mg/dL [0.7, 0.9] vs. 0.8 mg/dL [0.68, 1] p = 0.74 in those with and without preeclampsia. In normal patients, urinary podocalyxin decreased from 54.4 ng/mg [34.2, 76.9] during pregnancy to 7.66 ng/mg [2.35, 13] three years after pregnancy, p = 0.01. Proteinuria decreased from 123.5 mg/g [65.9, 194.8] to 43.2 mg/g [20.9, 139.3], p = 0.12. In preeclampsia patients, urinary podocalyxin decreased from 97.5 ng/mg [64.9, 318.4] during pregnancy to 37.1 ng/mg within one week post-partum [21.3, 100.4] p = 0.05 and 4.34 ng/mg [2.69, 8.99] three years after, p = 0.003. Proteinuria was 757.2 mg/g [268.4, 5031.7] during pregnancy vs. 757.2 mg/g [288.2, 2917] postpartum, p = 0.09 vs. 81.5 mg/g [60.6, 105.5] three years later, p = 0.01. Two patients still had proteinuria after 3 years. CONCLUSIONS: in preeclampsia patients, postpartum urinary podocalyxin decreased before proteinuria. After three years, serum creatinine, urinary podocalyxin, and protein tended to normalize, although some patients still had proteinuria. Sociedade Brasileira de Nefrologia 2018-05-17 2018 /pmc/articles/PMC6534005/ /pubmed/29782634 http://dx.doi.org/10.1590/2175-8239-JBN-3941 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
de Franco, Ylbe Palacios
Velazquez, Karina
Segovia, Natalia
Sandoval, Gladys
Gauto, Estefania
Palacios, Ylbe V. Franco
Palacios, Carlos R Franco
Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia
title Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia
title_full Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia
title_fullStr Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia
title_full_unstemmed Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia
title_short Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia
title_sort long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534005/
https://www.ncbi.nlm.nih.gov/pubmed/29782634
http://dx.doi.org/10.1590/2175-8239-JBN-3941
work_keys_str_mv AT defrancoylbepalacios longtermfollowupofbiomarkersofpodocytedamageandrenalfunctioninpatientswithandwithoutpreeclampsia
AT velazquezkarina longtermfollowupofbiomarkersofpodocytedamageandrenalfunctioninpatientswithandwithoutpreeclampsia
AT segovianatalia longtermfollowupofbiomarkersofpodocytedamageandrenalfunctioninpatientswithandwithoutpreeclampsia
AT sandovalgladys longtermfollowupofbiomarkersofpodocytedamageandrenalfunctioninpatientswithandwithoutpreeclampsia
AT gautoestefania longtermfollowupofbiomarkersofpodocytedamageandrenalfunctioninpatientswithandwithoutpreeclampsia
AT palaciosylbevfranco longtermfollowupofbiomarkersofpodocytedamageandrenalfunctioninpatientswithandwithoutpreeclampsia
AT palacioscarlosrfranco longtermfollowupofbiomarkersofpodocytedamageandrenalfunctioninpatientswithandwithoutpreeclampsia